The US Food and Drug Administration-approved Marie system promises human-centred care, advanced technology and lower costs.

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug delivery technology, today announced its successful participation in the ...

As drug development enters a new era, Certara is expanding its global team of scientists and technologists to lead the shift toward AI-powered testing methods.

A team of researchers in China has developed a promising biotechnological approach that could help communities worldwide ...

Discover key insights from McKesson’s Q2 2026 earnings call, including record growth, raised guidance, and strategic investments.

Renaissance Group Opens New $35M Position in Halozyme Therapeutics (NASDAQ: HALO): Why This Biotech Stock Is Worth a Look ...

Dr. Lorraine Thorpe, DC, Founder of Thorpe Chiropractic and Wellness in St. Petersburg, Florida, joined Gayle Guyardo, host ...

Clever Culture is bringing automation to pharma microbiology, with its AI tech now used by global heavyweights such as ...

The bidding war over biotechnology company Metsera (MTSR) has intensified, drawing fierce competition from pharmaceutical ...

The resignation of head drug regulator George Tidmarsh comes amid concerns about conduct related to the lupus nephritis drug ...

The official opening will be headlined by Dr Nomalungelo Gina, Deputy Minister of Science, Technology and Innovation, who ...

Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A ...